Topoisomerase I function during Escherichia coli response to antibiotics and stress enhances cell killing from stabilization of its cleavage complex

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 7, 2011, Pages 1518-1524

  Liu, I Fen ^a   Sutherland, Jeanette H ^a   Cheng, Bokun ^a   Tse Dinh, Yuk Ching ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Anti infective development; Drug targets; Gene expression; Killing; Stress response

Indexed keywords

DIND1 PROTEIN; DNA TOPOISOMERASE; LUCIFERASE; MITOMYCIN C; NITRITE; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL VIABILITY; CELL KILLING; DNA CLEAVAGE; ESCHERICHIA COLI; GENE ACTIVATION; GENE FUSION; GENE INDUCTION; MUTATION; NONHUMAN; PROMOTER REGION; PROTEIN FUNCTION; RECA GENE; TRANSCRIPTION INITIATION; TREATMENT RESPONSE; WESTERN BLOTTING;

ANTI-BACTERIAL AGENTS; ARTIFICIAL GENE FUSION; BLOTTING, WESTERN; DNA TOPOISOMERASES, TYPE I; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GENE DELETION; GENES, REPORTER; LUCIFERASES; MICROBIAL VIABILITY; MITOMYCIN; NITRITES; REC A RECOMBINASES; TRIMETHOPRIM;

EID: 79958778126     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr150     Document Type: Article

References (46)

1. Schoeffler AJ, Berger JM. DNA topoisomerases: harnessing and constraining energy to govern chromosome topology. Q Rev Biophys 2008; 41: 41-101.
2. Wang JC. Cellular roles of DNA topoisomerases: a molecular perspective. Nat Rev Mol Cell Biol 2002; 3: 430-40.
3. Mitscher LA. Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents. Chem Rev 2005; 105: 559-92.
4. Tse-Dinh YC. Exploring DNA topoisomerases as targets of novel therapeutic agents in the treatment of infectious diseases. Infect Disord Drug Targets 2007; 7: 3-9.
5. Nitiss JL. DNA topoisomerases in cancer chemotherapy: using enzymes to generate selective DNA damage. Curr Opin Investig Drugs 2002; 3: 1512-6.
6. Pommier Y, Leo E, Zhang H et al. DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol 2010; 17: 421-33.
7. Drlica K, Malik M, Kerns RJ et al. Quinolone-mediated bacterial death. Antimicrob Agents Chemother 2008; 52: 385-92.
8. Hooper DC. Quinolone mode of action. Drugs 1995; 49 Suppl 2: 10-5.
9. Dwyer DJ, Kohanski MA, Hayete B et al. Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli. Mol Syst Biol 2007; 3: 91.
10. Kohanski MA, Dwyer DJ, Hayete B et al. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 2007; 130: 797-810.
11. Forterre P, Gadelle D. Phylogenomics of DNA topoisomerases: their origin and putative roles in the emergence of modern organisms. Nucleic Acids Res 2009; 37: 679-92.
12. Tse-Dinh YC. Bacterial topoisomerase I as a target for discovery of antibacterial compounds. Nucleic Acids Res 2009; 37: 731-7.
13. Cheng B, Shukla S, Vasunilashorn S et al. Bacterial cell killing mediated by topoisomerase I DNA cleavage activity. J Biol Chem 2005; 280: 38489-95.
14. Liu IF, Annamalai T, Sutherland JH et al. Hydroxyl radicals are involved in cell killing by the bacterial topoisomerase I cleavage complex. J Bacteriol 2009; 191: 5315-9.
15. Sutherland JH, Cheng B, Liu IF et al. SOS induction by stabilized topoisomerase IA cleavage complex occurs via the RecBCD pathway. J Bacteriol 2008; 190: 3399-403.
16. Garcia MT, Blazquez MA, Ferrandiz MJ et al. New alkaloid antibiotics that target the DNA topoisomerase I of Streptococcus pneumoniae. J Biol Chem 2011; 286: 6402-13.
17. Cheng B, Liu I, Tse-Dinh YC. Compounds with antibacterial activity that enhance DNA cleavage by bacterial DNA topoisomerase I. J Antimicrob Chemother 2007; 59: 640-5.
18. Drolet M. Growth inhibition mediated by excess negative supercoiling: the interplay between transcription elongation, R-loop formation and DNA topology. Mol Microbiol 2006; 59: 723-30.
19. Blot N, Mavathur R, Geertz M et al. Homeostatic regulation of supercoiling sensitivity coordinates transcription of the bacterial genome. EMBO Rep 2006; 7: 710-5.
20. Rui S, Tse-Dinh YC. Topoisomerase function during bacterial responses to environmental challenge. Front Biosci 2003; 8: d256-63.
21. Cheung KJ, Badarinarayana V, Selinger DW et al. A microarray-based antibiotic screen identifies a regulatory role for supercoiling in the osmotic stress response of Escherichia coli. Genome Res 2003; 13: 206-15.
22. Lesley SA, Jovanovich SB, Tse-Dinh YC et al. Identification of a heat shock promoter in the topA gene of Escherichia coli. J Bacteriol 1990; 172: 6871-4.
23. Qi H, Menzel R, Tse-Dinh YC. Regulation of Escherichia coli topA gene transcription: involvement of a sS-dependent promoter. J Mol Biol 1997; 267: 481-9.
24. Liu LF, Wang JC. Supercoiling of the DNA template during transcription. Proc Natl Acad Sci USA 1987; 84: 7024-7.
25. Cheng B, Rui S, Ji C et al. RNase H overproduction allows the expression of stress-induced genes in the absence of topoisomerase I. FEMS Microbiol Lett 2003; 221: 237-42.
26. Drolet M, Phoenix P, Menzel R et al. Overexpression of RNase H partially complements the growth defect of an Escherichia coli DtopA mutant: R-loop formation is a major problem in the absence of DNA topoisomerase I. Proc Natl Acad Sci USA 1995; 92: 3526-30.
27. Cheng B, Zhu CX, Ji C et al. Direct interaction between Escherichia coli RNA polymerase and the zinc ribbon domains of DNA topoisomerase I. J Biol Chem 2003; 278: 30705-10.
28. Qi H, Menzel R, Tse-Dinh YC. Increased thermosensitivity associated with topoisomerase I deletion and promoter mutations in Escherichia coli. FEMS Microbiol Lett 1999; 178: 141-6.
29. Qi H, Menzel R, Tse-Dinh YC. Effect of the deletion of the sigma 32-dependent promoter (P1) of the Escherichia coli topoisomerase I gene on thermotolerance. Mol Microbiol 1996; 21: 703-11.
30. Tse-Dinh YC. Increased sensitivity to oxidative challenges associated with topA deletion in Escherichia coli. J Bacteriol 2000; 182: 829-32.
31. Stewart N, Feng J, Liu X et al. Loss of topoisomerase I function affects the RpoS-dependent and GAD systems of acid resistance in Escherichia coli. Microbiology 2005; 151: 2783-91.
32. Dwyer DJ, Kohanski MA, Collins JJ. Role of reactive oxygen species in antibiotic action and resistance. Curr Opin Microbiol 2009; 12: 482-9.
33. Da Re S, Garnier F, Guerin E et al. The SOS response promotes qnrB quinolone-resistance determinant expression. EMBO Rep 2009; 10: 929-33.
34. Beaber JW, Hochhut B, Waldor MK. SOS response promotes horizontal dissemination of antibiotic resistance genes. Nature 2004; 427: 72-4.
35. Singh R, Ledesma KR, Chang KT et al. Impact of recA on levofloxacin exposure-related resistance development. Antimicrob Agents Chemother 2010; 54: 4262-8.
36. Cheng B, Annamalai T, Sorokin E et al. Asp-to-Asn substitution at the first position of the DxD TOPRIM motif of recombinant bacterial topoisomerase I is extremely lethal to E. coli. J Mol Biol 2009; 385: 558-67.
37. Van Dyk TK, Wei Y, Hanafey MK et al. A genomic approach to gene fusion technology. Proc Natl Acad Sci USA 2001; 98: 2555-60.
38. O'Reilly EK, Kreuzer KN. Isolation of SOS constitutive mutants of Escherichia coli. J Bacteriol 2004; 186: 7149-60.
39. Tomasz M, Palom Y. The mitomycin bioreductive antitumor agents: cross-linking and alkylation of DNA as the molecular basis of their activity. Pharmacol Ther 1997; 76: 73-87.
40. Amyes SG, Smith JT. Trimethoprim action and its analogy with thymine starvation. Antimicrob Agents Chemother 1974; 5: 169-78.
41. Weinstein-Fischer D, Elgrably-Weiss M, Altuvia S. Escherichia coli response to hydrogen peroxide: a role for DNA supercoiling, topoisomerase I and Fis. Mol Microbiol 2000; 35: 1413-20.
42. Fang FC. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat Rev Microbiol 2004; 2: 820-32.
43. Bower JM, Mulvey MA. Polyamine-mediated resistance of uropathogenic Escherichia coli to nitrosative stress. J Bacteriol 2006; 188: 928-33.
44. Pruss GJ, Manes SH, Drlica K. Escherichia coli DNA topoisomerase I mutants: increased supercoiling is corrected by mutations near gyrase genes. Cell 1982; 31: 35-42.
45. DiNardo S, Voelkel KA, Sternglanz R et al. Escherichia coli DNA topoisomerase I mutants have compensatory mutations in DNA gyrase genes. Cell 1982; 31: 43-51.
46. Dorr T, Lewis K, Vulic M. SOS response induces persistence to fluoroquinolones in Escherichia coli. PLoS Genet 2009; 5: e1000760.